An HIV protease inhibitor is called Viracept (nelfinavir). Human immunodeficiency virus (HIV) cells are prevented from proliferating in your body by Viracept.HIV, which causes acquired immunodeficiency syndrome (AIDS), is treated with Viracept. Viracept is not an HIV or AIDS treatment.The use of Viracept is not limited to those conditions detailed in this medication guide. This article is written to provide information about Viracept to Welzo users.

Health Benefits

It has been demonstrated that Viracept works well to lower viral loads and boost CD4 cell counts in HIV-infected individuals. Additionally, Viracept has been linked to a decline in the occurrence of opportunistic infections related to HIV.

Side Effects

The following are typical Viracept side effects:



belly pain,



slimming down,

migraine, and


The following are serious side effects of Viracept:

extreme diarrhoea (bloody or watery stools),

flu-like symptoms such as a fever, chills, body aches, and mouth and throat sores;

dark urine, pale oryellowed skin, or

Jaundice is a skin or eye yellowing condition.

If you experience any of these serious side effects, contact your doctor right away.

Dosage and Administration

Viracept is offered as a tablet or oral solution. Adults are advised to take 750 mg twice daily. 350 mg/m2 twice daily is the recommended dosage for kids between the ages of 2 and 17.

Patients with renal or hepatic impairment may require dosage adjustments.

It is best to take Viracept with food.


Other medications, particularly rifampin, St. John's wort, seizure medications, or antibiotics, may interact with viracept. Give your doctor a complete list of all the drugs and supplements you take. Viracept should only be used during pregnancy when prescribed. This medication is excreted in breast milk and could harm a nursing infant. Before breastfeeding, speak with your doctor. If you are allergic to nelfinavir, suffer from liver disease, or have a history of pancreatitis, you should not take this medication.

Mechanism of Action

HIV protease, an enzyme required for the HIV virus to develop and generate contagious particles, is inhibited by Viracept. Viracept helps prevent HIV replication by reducing the amount of the virus in the blood and inhibiting this enzyme.


The digestive system quickly and completely absorbs viracept. The oral solution's bioavailability is comparable to the tablet's. The presence of nelfinavir is widespread in bodily fluids and tissues. The typical half-life of plasma elimination is 4 hours. The liver breaks down nelfinavir, which is mainly eliminated in feces.